| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Bridgebio Pharma, Inc.'s insiders have reduced their positions by a net 56,980 shares worth roughly $4.6M.
BBIO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 919.9K | - | - | |
| CEO | 497.0K | $34.30M | - | |
| CFO | 336.5K | $26.88M | - | |
| Other | 122.7K | $9.80M | - | |
| Dir | 120.8K | $10.15M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Lo Andrew | Director | Sell | 95,599 | $66.11 | $6,319,662.43 | -65.4% | +15.6% | - | |
| Nov 17, 2025 | Scott Randal W.45 | Director | Sale+OE | 10,000 | $66.65 | $666,465.10 | -46.3% | +13.4% | - | |
| Nov 17, 2025 | Trimarchi Thomas | President And CFO | Sell | 16,934 | $66.46 | $1,125,404.42 | -4.2% | +13.4% | - | |
| Nov 12, 2025 | Valantine Hannah51 | Director | Sale+OE | 25,484 | $66.07 | $1,683,727.88 | -77.3% | +9.4% | - | |
| Nov 7, 2025 | Kumar Neil | Chief Executive Officer | Sell | 80,000 | $62.29 | $4,983,111.08 | -9.1% | +3.1% | - | |
| Nov 6, 2025 | Daniels Ronald J | Director | Sale+OE | 61,031 | $63.72 | $3,888,999.07 | -78.2% | +19.9% | - | |
| Oct 29, 2025 | McCormick Frank | Director | Sell | 198,359 | $66.58 | $13,206,527.70 | -22.6% | +16.9% | - | |
| Oct 27, 2025 | McCormick Frank | Director | Sell | 1,641 | $65.00 | $106,665.00 | -0.2% | +22.4% | - | |
| Oct 9, 2025 | Kumar Neil | Chief Executive Officer | Sell | 80,000 | $54.79 | $4,383,442.21 | -8.7% | +35.6% | - | |
| Sep 5, 2025 | McCormick Frank | Director | Sale+OE | 74,000 | $53.16 | $3,933,544.00 | -47.1% | +40.1% | - |